Search Results 431-440 of 17231 for GLP-1 therapy
... 1 diabetes. Kate Ledger. August 1, 2025. Mayo Clinic treats first person in the US with a novel radiopharmaceutical therapy for breast cancer. Cancer. Mayo ...
The purpose of this study is to demonstrate the safety and tolerability of JAB-3312 in combination with anti-PD-1 mAb or MEKi or KRASi or EGFR-TKI in patients ...
Mayo Clinic has one ... Determining the most appropriate treatment for people who have high blood pressure caused by renal artery stenosis. ... Had to reduce blood ...
... Therapy. Rochester, Minn. The purpose of this study is to estimate the efficacy of LUTATHERA treatment in patients with recurrent grade 1 meningioma as ...
... 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market. Study IDs. Site IRB.
Planned SoC SBRT as definitive treatment (see Appendix H) using one of the following doses: For peripheral tumors: 54 Gy total dose delivered in 3 fractions ...
Heart & Blood Health Discussions. ldjones99 · Had to reduce blood pressure meds due to GLP-1. Anyone else? 2 Replies Fri, Dec ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Hurry to 3X your gift’s impact on cancer research and care!